Hénon, Philippe http://orcid.org/0000-0002-8798-5994
Kowalczyk, Marc
Aries, Anne
Vignon, Christine
Trébuchet, Guillaume
Lahlil, Rachid
Article History
Accepted: 3 April 2022
First Online: 14 April 2022
Declarations
:
: Informed consent was obtained from all subjects involved in the study.
: CellProthera owns IP on the GMP-compliant in vitro expansion and production of CD34<sup>+</sup> cells for clinical use (StemXpand<sup>®</sup>, StemPack<sup>®</sup> and ProtheraCytes<sup>®</sup>). P.H.; M.K., G.T., and C.V. are staff members of CellProthera.